Call for Abstract
Scientific Program
World Congress on Pharmacology, will be organized around the theme “Tracking and Tackling Drug Developments in Pharmacology”
Pharmacology-2015 is comprised of 16 tracks and 75 sessions designed to offer comprehensive sessions that address current issues in Pharmacology-2015.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Drug interactions and pharmacological compatibilities
- Track 1-2Receptor theory for drug effects
- Track 1-3Clinical efficacy and safety evaluation
- Track 1-4Novel options for the pharmacological treatment of chronic diseases
- Track 2-1Neuro signaling and its pathways
- Track 2-2Neurogenesis and repair
- Track 2-3Neuro Immune pharmacology and its associated diseases
- Track 2-4Neurocognitive effects associated with therapeutic drugs
- Track 2-5Dose response relation in psychiatric medications
- Track 2-6Effect of androgenic anabolic steroids on psychosis
- Track 3-1Surgical therapy and associate drugs
- Track 3-2Radiation therapy and its implications
- Track 3-3Physical therapy and its advances
- Track 4-1Cancer pharmcogenetics
- Track 4-2Recent advances in DNA repair
- Track 4-3Pharamcogenetic approach involved in modulating cell processes
- Track 4-4Mutagenecity- its implications in cancer following chemotherapy
- Track 4-5Drug dosing guidelines
- Track 4-6Recent advances in variant-disease pairs
- Track 5-1Molecular epidemiology and its biomarkers
- Track 5-2Molecular pathological epidemiology
- Track 5-3Pharmacovigilance and post marketing surveillance
- Track 5-4Adverse event reporting system
- Track 6-1Sources of therapeutic errors and drug toxicity
- Track 6-2Principles of management of a poisoned patient
- Track 6-3Toxicity associated with metabolites
- Track 6-4Teratogenicity and embryo toxicity
- Track 6-5Applications and challenges in death investigations
- Track 6-6Hypothesis and data driven research
- Track 7-1Bioequivalence and physiochemical properties of the drugs
- Track 7-2Ligand based drug design techniques
- Track 7-3Recombinant DNA technology
- Track 7-4Bioinformatics: Bioinformatics solutions to complex biological problems
- Track 7-5Proteomics
- Track 7-6Pharmacokinetics and Pharmacodynamics of Drugs
- Track 8-1Drug disposition and metabolism
- Track 8-2Drug withdrawal aspects
- Track 8-3Chemical dependency
- Track 8-4Drug tolerance
- Track 8-5Hangover
- Track 8-6Drug detoxification
- Track 9-1Effect of gene expression in endothelial cells
- Track 9-2Vascular biology
- Track 9-3Pharmacology of drugs affecting fluid and electrolyte balance
- Track 9-4Pharmacology of drugs affecting vascular tone
- Track 10-1Pharmacology of the Vascular endothelium
- Track 10-2Pharmacology of drugs affecting vascular tone and blood pressure
- Track 10-3Role of drugs in coronary circulation
- Track 10-4Drugs and the electrical conduction of the heart
- Track 10-5Drugs and the failing heart
- Track 11-1Integrative Pharmacological Investigations
- Track 11-2Ethnopharmacological perspectives from traditional to modern pharmaceuticals.
- Track 11-3Natural products chemistry in drug discovery
- Track 11-4Chemistry and structural elucidation
- Track 11-5Natural and synthetic derivatives in pharmacological studies
- Track 12-1Techniques: The application of accelerator mass spectrometry to pharmacology and toxicology
- Track 12-2Liposomes and nanoparticles: nanosized vehicles for drug delivery
- Track 12-3Epigenetic mechanisms of importance for drug treatment
- Track 12-4Pharmacometrics
- Track 13-1Classical pharmacology
- Track 13-2Reverse pharmacology
- Track 13-3Target based drug discovery
- Track 13-4Screening of chemical libraries and its pharmacology
- Track 13-5Methods To determine biological targeting
- Track 14-1Adverse effects of therapeutic agents
- Track 14-2Pharmaco- and toxico-epidemiology
- Track 14-3Toxicokinetic/toxicodynamic modelling
- Track 14-4Immunopharmacology
- Track 14-5Pharmacokinetics and Pharmacodynamics
- Track 14-6Legal and regulatory evaluation of dugs
- Track 15-1Prospective impact of new risk management guidelines on core labeling
- Track 15-2Data mining concepts and techniques
- Track 15-3Review of softwares used in pharmacovigilance and clinical trials
- Track 15-4Alternative trials design and models
- Track 15-5Interpreting safety signals